(Q63594784)
Statements
12-weeks, Multicentre, Randomized, Double-blind, Placebo-controlled, Exploratory, Pilot Study to Evaluate the Efficacy and Safety of Safinamide 200 mg OD, as add-on Therapy, in Patients With Possible or Probable Parkinsonian Variant of MSA (English)
0 references
31 March 2019
0 references
31 March 2020
0 references
30
0 references
30 year
0 references
80 year
0 references